Detalles de la búsqueda
1.
Global COVID-19 Vaccination in Infants and Children: Effectiveness, Safety, and Challenges.
Asian Pac J Allergy Immunol
; 41(4): 292-303, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37874316
2.
Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
Asian Pac J Allergy Immunol
; 40(3): 269-277, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717527
3.
Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children.
Vaccine X
; 15: 100414, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38090644
4.
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
Int J Infect Dis
; 130: 52-59, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36841501
5.
Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.
Vaccine X
; 15: 100367, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601322
6.
High Transmission Rates of Early Omicron Subvariant BA.2 in Bangkok, Thailand.
Adv Virol
; 2023: 4940767, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38094619
7.
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
Vaccine
; 41(40): 5834-5840, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586956
8.
Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents.
Vaccines (Basel)
; 10(7)2022 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891264
9.
Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents.
Vaccine X
; 12: 100211, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059600
10.
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.
Vaccine X
; 12: 100221, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36213592
11.
Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases.
Vaccines (Basel)
; 10(6)2022 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746478
12.
Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents.
Vaccines (Basel)
; 10(10)2022 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298510
13.
Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers.
Vaccines (Basel)
; 10(5)2022 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35632395
14.
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecoviruses.
Res Sq
; 2022 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233568
15.
SARS-CoV-2 Omicron variant emerged under immune selection.
Nat Microbiol
; 7(11): 1756-1761, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195753
16.
Clinical outcomes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand.
IJID Reg
; 1: 159-162, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35721777
17.
Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children.
Int J Infect Dis
; 112: 89-95, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34547486
Resultados
1 -
17
de 17
1
Próxima >
>>